HemaSphere (Aug 2023)
S168: PELABRESIB (CPI-0610) MONOTHERAPY IN PATIENTS WITH HIGH-RISK ESSENTIAL THROMBOCYTHEMIA REFRACTORY OR INTOLERANT TO HYDROXYUREA: PRELIMINARY RESULTS FROM MANIFEST STUDY
- Francesco Passamonti,
- Andrea Patriarca,
- Steven Knapper,
- Candido Rivera,
- Joseph M Scandura,
- Timothy Devos,
- Nikki Granacher,
- Adam Mead,
- Stephen Oh,
- Jeanne Palmer,
- Raajit K Rampal,
- Lino Teichmann,
- Qing LI,
- Jean-Pierre Eliane,
- Tzuu-Wang Chang,
- Sandra Klein,
- Gozde Colak,
- Claire Harrison
Affiliations
- Francesco Passamonti
- 1 University of Insubria, Varese, Italy
- Andrea Patriarca
- 2 Hematology Unit, Department of Translational Medicine, University of Eastern Piedmont and AOU Maggiore della Carità, Novara, Italy
- Steven Knapper
- 3 Department of Haematology, Division of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, United Kingdom
- Candido Rivera
- 4 Mayo Clinic Florida, Jacksonville, United States
- Joseph M Scandura
- 5 The Richard T. Silver, M.D. Myeloproliferative Neoplasms Center, Division of Hematology and Oncology, Cornell Medicine, New York, United States
- Timothy Devos
- 6 Department of Hematology, University Hospitals Leuven and Laboratory of Molecular Immunology (Rega Institute), KU Leuven, Leuven, Belgium
- Nikki Granacher
- 7 Ziekenhuis Netwerk Antwerpen, Antwerp, Belgium
- Adam Mead
- 8 MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom
- Stephen Oh
- 9 Washington University School of Medicine in St. Louis, St. Louis, United States
- Jeanne Palmer
- 10 Mayo Clinic Arizona, Phoenix, United States
- Raajit K Rampal
- 11 Memorial Sloan Kettering Cancer Center, New York, United States
- Lino Teichmann
- 12 Universitätsklinikum Bonn, Bonn, Germany
- Qing LI
- 13 Constellation Pharmaceuticals, Inc., a MorphoSys Company, Boston, United States
- Jean-Pierre Eliane
- 13 Constellation Pharmaceuticals, Inc., a MorphoSys Company, Boston, United States
- Tzuu-Wang Chang
- 13 Constellation Pharmaceuticals, Inc., a MorphoSys Company, Boston, United States
- Sandra Klein
- 13 Constellation Pharmaceuticals, Inc., a MorphoSys Company, Boston, United States
- Gozde Colak
- 13 Constellation Pharmaceuticals, Inc., a MorphoSys Company, Boston, United States
- Claire Harrison
- 14 Guy’s and St Thomas’ NHS Foundation Trust, London, United Kingdom
- DOI
- https://doi.org/10.1097/01.HS9.0000967584.99278.43
- Journal volume & issue
-
Vol. 7
p. e9927843
Abstract
No abstracts available.